@wandalllab.bsky.social
Launching the Copenhagen Center for Glycocalyx Research (CGR) at @UCPH! We study how cellular signals reshape the glycocalyx to power better diagnostics and targeted therapies—now joining forces with #JesperVelgaardOlsen at the Center for Protein Research. Grateful to #DNRF and our advisors!
October 13, 2025 at 6:57 AM
Launching the Copenhagen Center for Glycocalyx Research (CGR) at @UCPH! We study how cellular signals reshape the glycocalyx to power better diagnostics and targeted therapies—now joining forces with #JesperVelgaardOlsen at the Center for Protein Research. Grateful to #DNRF and our advisors!
We need to expand treatment options for more cancer patients! Excited to help drive innovation in cancer care with GO’s advanced glycopeptide platform, delivering next-gen clean targets to ADCs, CAR Ts, and bispecifics.
pharma.h5mag.com/pharma_sep24...
pharma.h5mag.com/pharma_sep24...
Era of ADCs: Pharma companies innovate to stand out in a buzzing market - Pharma Technology Focus | Issue 146 | September 2024
As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biotechs are using newer targets and linkers to differentiate themselves.
pharma.h5mag.com
November 24, 2024 at 3:01 PM
We need to expand treatment options for more cancer patients! Excited to help drive innovation in cancer care with GO’s advanced glycopeptide platform, delivering next-gen clean targets to ADCs, CAR Ts, and bispecifics.
pharma.h5mag.com/pharma_sep24...
pharma.h5mag.com/pharma_sep24...